If you have been reading about AOD-9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-08-26. Numbers and descriptions here follow the published literature rather than marketing material.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
When glucose binds to the glucose transporter, the protein channels change shape and undergo a conformational change to transport the glucose across the membrane. Once the glucose unbinds, the protein returns to its original shape. The glucose transporter is essential for carrying out physiological processes that require high energy demands in the brain, muscles, and kidneys by providing an adequate amount of energy substrate for metabolism. Diabetes, an example of a condition that involves glucose metabolism, highlights the importance of the regulation of glucose uptake in disease management.
Merck Millipore was the brand used by Merck Group's (not US-based Merck & Co.) global life science business until 2015 when the company re-branded. It was formed when Merck acquired the Millipore Corporation in 2010. Merck is a supplier to the life science industry. The Millipore Corporation was founded in 1954, and listed among the S&P 500 since the early 1990s, as an international biosciences company which makes micrometer pore-size filters and tests. In 2015, Merck acquired Sigma-Aldrich and merged it with Merck Millipore. In the United States and Canada, the life science business is now known as MilliporeSigma.
Pseudoprolines are a powerful tool for improving the quality of synthetic peptides. Pseudoproline dipeptides have greatly increased the success rate for synthesizing both long and difficult peptides. Pseudoproline dipeptides can be introduced in the same manner as other amino acid derivatives. The routine use of pseudoproline (oxazolidine) dipeptides in the FMOC solid phase peptide synthesis (SPPS) of serine- and threonine-containing peptides leads to remarkable improvements in quality and yield of crude products and helps avoid unnecessary repeat synthesis of failed sequences. Pseudoproline dipeptides have proven particularly effective in the synthesis of intractable peptides, long peptides/small proteins, and cyclic peptides, enabling in many cases the production of peptides that otherwise could not be made. These dipeptides are extremely easy to use: simply substitute a serine or threonine residue together with the preceding amino acid residue in the peptide sequence with the appropriate pseudoproline dipeptide (see the figure on your right). The native sequence is regenerated on cleavage and deprotection.
Jung's thought derived from the classical education he received at school and from early family influences, which on the maternal side were a combination of Reformed Protestant academic theology with an interest in occult phenomena. On his father's side was a dedication to academic discipline emanating from his grandfather - the physician, scientist, one-time student activist and convert from Catholicism to Swiss Reformed Protestantism, and first Basel Professor of Medicine, Karl Gustav Jung. Family lore also suggested there was at least a social connection to the German polymath, Johann Wolfgang Goethe, through the latter's niece, Lotte Kestner (known as "Lottchen") who was a frequent visitor in Jung senior's household. Jung had, through his marriage, the economic security to pursue interests in other intellectual topics of the moment. His early celebrity as a research scientist through the Word Association Test led to the start of prolific correspondence and worldwide travel. It opened academic as well as social avenues, supported by his explorations into anthropology, quantum physics, vitalism, Eastern and Western philosophy. He delved into epistemology, alchemy, astrology, and sociology, as well as literature and the arts. Jung's interest in philosophy and spiritual subjects led many to label him a mystic, although he preferred to be seen as a man of science. Jung, unlike Freud, was deeply knowledgeable about philosophical concepts and sought links between epistemology and emergent theories of psychology.
Sources: en.wikipedia.org
== See also == List of pre-Columbian cultures Domesticated plants of Mesoamerica Agriculture in Mesoamerica Mesoamerican cuisine Mesoamerican diet and subsistence Mesoamerican architecture Indigenous music of North America Painting in the Americas before European colonization Mesoamerican chronology History portal North America portal Central America portal South America portal
=== EC 2.3.1: Transferring groups other than amino-acyl groups === EC 2.3.1.1: amino-acid N-acetyltransferase EC 2.3.1.2: imidazole N-acetyltransferase EC 2.3.1.3: glucosamine N-acetyltransferase EC 2.3.1.4: glucosamine-phosphate N-acetyltransferase EC 2.3.1.5: arylamine N-acetyltransferase EC 2.3.1.6: choline O-acetyltransferase EC 2.3.1.7: carnitine O-acetyltransferase EC 2.3.1.8: phosphate acetyltransferase EC 2.3.1.9: acetyl-CoA C-acetyltransferase EC 2.3.1.10: hydrogen-sulfide S-acetyltransferase EC 2.3.1.11: thioethanolamine S-acetyltransferase EC 2.3.1.12: dihydrolipoyllysine-residue acetyltransferase EC 2.3.1.13: glycine N-acyltransferase EC 2.3.1.14: glutamine N-phenylacetyltransferase EC 2.3.1.15: glycerol-3-phosphate O-acyltransferase EC 2.3.1.16: acetyl-CoA C-acyltransferase EC 2.3.1.17: aspartate N-acetyltransferase EC 2.3.1.18: galactoside O-acetyltransferase EC 2.3.1.19: phosphate butyryltransferase EC 2.3.1.20: diacylglycerol O-acyltransferase EC 2.3.1.21: carnitine O-palmitoyltransferase EC 2.3.1.22: 2-acylglycerol O-acyltransferase EC 2.3.1.23: 1-acylglycerophosphocholine O-acyltransferase EC 2.3.1.24: sphingosine N-acyltransferase EC 2.3.1.25: plasmalogen synthase EC 2.3.1.26: sterol O-acyltransferase EC 2.3.1.27: cortisol O-acetyltransferase EC 2.3.1.28: chloramphenicol O-acetyltransferase EC 2.3.1.29: glycine C-acetyltransferase EC 2.3.1.30: serine O-acetyltransferase EC 2.3.1.31: homoserine O-acetyltransferase EC 2.3.1.32: lysine N-acetyltransferase EC 2.3.1.33: histidine N-acetyltransferase EC 2.3.1.34: D-tryptophan N-acetyltransferase EC 2.3.1.35: glutamate N-acetyltransferase EC 2.3.1.36: D-amino-acid N-acetyltransferase EC 2.3.1.37: 5-aminolevulinate synthase EC 2.3.1.38: [acyl-carrier-protein] S-acetyltransferase EC 2.3.1.39: [acyl-carrier-protein] S-malonyltransferase EC 2.3.1.40: acyl-[acyl-carrier-protein]—phospholipid O-acyltransferase EC 2.3.1.41: β-ketoacyl-[acyl-carrier-protein] synthase I EC 2.3.1.42: glycerone-phosphate O-acyltransferase EC 2.3.1.43: phosphatidylcholine—sterol O-acyltransferase EC 2.3.1.44: N-acetylneuraminate 4-O-acetyltransferase EC 2.3.1.45: N-acetylneuraminate 7-O(or 9-O)-acetyltransferase EC 2.3.1.46: homoserine O-succinyltransferase EC 2.3.1.47: 8-amino-7-oxononanoate synthase EC 2.3.1.48: histone acetyltransferase EC 2.3.1.49: deacetyl-(citrate-(pro-3S)-lyase) S-acetyltransferase EC 2.3.1.50: serine C-palmitoyltransferase EC 2.3.1.51: 1-acylglycerol-3-phosphate O-acyltransferase EC 2.3.1.52: 2-acylglycerol-3-phosphate O-acyltransferase EC 2.3.1.53: phenylalanine N-acetyltransferase EC 2.3.1.54: formate C-acetyltransferase EC 2.3.1.55: identical to EC 2.3.1.82 EC 2.3.1.56: aromatic-hydroxylamine O-acetyltransferase EC 2.3.1.57: diamine N-acetyltransferase EC 2.3.1.58: 2,3-diaminopropionate N-oxalyltransferase EC 2.3.1.59: gentamicin 2′-N-acetyltransferase EC 2.3.1.60: gentamicin 3′-N-acetyltransferase EC 2.3.1.61: dihydrolipoyllysine-residue succinyltransferase EC 2.3.1.62: 2-acylglycerophosphocholine O-acyltransferase EC 2.3.1.63: 1-alkylglycerophosphocholine O-acyltransferase EC 2.3.1.64: agmatine N4-coumaroyltransferase EC 2.3.1.65: bile acid-CoA:amino acid N-acyltransferase EC 2.3.1.66: leucine N-acetyltransferase EC 2.3.1.67: 1-alkylglycerophosphocholine O-acetyltransferase EC 2.3.1.68: glutamine N-acyltransferase EC 2.3.1.69: monoterpenol O-acetyltransferase EC 2.3.1.70: deleted EC 2.3.1.71: glycine N-benzoyltransferase EC 2.3.1.72: indoleacetylglucose—inositol O-acyltransferase EC 2.3.1.73: diacylglycerol—sterol O-acyltransferase EC 2.3.1.74: chalcone synthase EC 2.3.1.75: long-chain-alcohol O-fatty-acyltransferase EC 2.3.1.76: retinol O-fatty-acyltransferase EC 2.3.1.77: triacylglycerol—sterol O-acyltransferase EC 2.3.1.78: heparan-α-glucosaminide N-acetyltransferase EC 2.3.1.79: maltose O-acetyltransferase EC 2.3.1.80: cysteine-S-conjugate N-acetyltransferase EC 2.3.1.81: aminoglycoside 3-N-acetyltransferase EC 2.3.1.82: aminoglycoside 6′-N-acetyltransferase EC 2.3.1.83: phosphatidylcholine—dolichol O-acyltransferase EC 2.3.1.84: alcohol O-acetyltransferase EC 2.3.1.85: fatty-acid synthase system EC 2.3.1.86: fatty-acyl-CoA synthase system EC 2.3.1.87: aralkylamine N-acetyltransferase EC 2.3.1.88: Now covered by EC 2.3.1.254, EC 2.3.1.255, EC 2.3.1.256, EC 2.3.1.257, EC 2.3.1.258 and EC 2.3.1.259 EC 2.3.1.89: tetrahydrodipicolinate N-acetyltransferase EC 2.3.1.90: β-glucogallin O-galloyltransferase EC 2.3.1.91: sinapoylglucose—choline O-sinapoyltransferase EC 2.3.1.92: sinapoylglucose—malate O-sinapoyltransferase EC 2.3.1.93: 13-hydroxylupinine O-tigloyltransferase EC 2.3.1.94: 6-deoxyerythronolide-B synthase EC 2.3.1.95: trihydroxystilbene synthase EC 2.3.1.96: glycoprotein N-palmitoyltransferase EC 2.3.1.97: glycylpeptide N-tetradecanoyltransferase EC 2.3.1.98: chlorogenate—glucarate O-hydroxycinnamoyltransferase EC 2.3.1.99: quinate O-hydroxycinnamoyltransferase EC 2.3.1.100: [myelin-proteolipid] O-palmitoyltransferase EC 2.3.1.101: formylmethanofuran—tetrahydromethanopterin N-formyltransferase EC 2.3.1.102: N6-hydroxylysine O-acetyltransferase EC 2.3.1.103: sinapoylglucose—sinapoylglucose O-sinapoyltransferase EC 2.3.1.104: The activity is covered by EC 2.3.1.25 EC 2.3.1.105: alkylglycerophosphate 2-O-acetyltransferase EC 2.3.1.106: tartronate O-hydroxycinnamoyltransferase EC 2.3.1.107: deacetylvindoline O-acetyltransferase EC 2.3.1.108: α-tubulin N-acetyltransferase EC 2.3.1.109: arginine N-succinyltransferase EC 2.3.1.110: tyramine N-feruloyltransferase EC 2.3.1.111: mycocerosate synthase EC 2.3.1.112: D-tryptophan N-malonyltransferase EC 2.3.1.113: anthranilate N-malonyltransferase EC 2.3.1.114: 3,4-dichloroaniline N-malonyltransferase EC 2.3.1.115: isoflavone-7-O-β-glucoside 6′′-O-malonyltransferase EC 2.3.1.116: flavonol-3-O-β-glucoside O-malonyltransferase EC 2.3.1.117: 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase EC 2.3.1.118: N-hydroxyarylamine O-acetyltransferase EC 2.3.1.119: Now covered by EC 2.3.1.199, EC 1.1.1.330, EC 4.2.1.134 and EC 1.3.1.93 EC 2.3.1.120: The reaction is due to EC 2.3.1.74 EC 2.3.1.121: 1-alkenylglycerophosphoethanolamine O-acyltransferase EC 2.3.1.122: trehalose O-mycolyltransferase EC 2.3.1.123: dolichol O-acyltransferase EC 2.3.1.124: Already listed as EC 2.3.1.20 EC 2.3.1.125: 1-alkyl-2-acetylglycerol O-acyltransferase EC 2.3.1.126: isocitrate O-dihydroxycinnamoyltransferase EC 2.3.1.127: ornithine N-benzoyltransferase EC 2.3.1.128: now classified as EC 2.3.1.266 and EC 2.3.1.267 EC 2.3.1.129: acyl-[acyl-carrier-protein]—UDP-N-acetylglucosamine O-acyltransferase EC 2.3.1.130: galactarate O-hydroxycinnamoyltransferase EC 2.3.1.131: glucarate O-hydroxycinnamoyltransferase EC 2.3.1.132: glucarolactone O-hydroxycinnamoyltransferase EC 2.3.1.133: shikimate O-hydroxycinnamoyltransferase EC 2.3.1.134: galactolipid O-acyltransferase EC 2.3.1.135: phosphatidylcholine—retinol O-acyltransferase EC 2.3.1.136: polysialic-acid O-acetyltransferase EC 2.3.1.137: carnitine O-octanoyltransferase EC 2.3.1.138: putrescine N-hydroxycinnamoyltransferase EC 2.3.1.139: ecdysone O-acyltransferase EC 2.3.1.140: rosmarinate synthase EC 2.3.1.141: galactosylacylglycerol O-acyltransferase EC 2.3.1.142: glycoprotein O-fatty-acyltransferase EC 2.3.1.143: β-glucogallin—tetrakisgalloylglucose O-galloyltransferase EC 2.3.1.144: anthranilate N-benzoyltransferase EC 2.3.1.145: piperidine N-piperoyltransferase EC 2.3.1.146: pinosylvin synthase EC 2.3.1.147: glycerophospholipid arachidonoyl-transferase (CoA-independent) EC 2.3.1.148: glycerophospholipid acyltransferase (CoA-dependent) EC 2.3.1.149: platelet-activating factor acetyltransferase EC 2.3.1.150: salutaridinol 7-O-acetyltransferase EC 2.3.1.151: 2,3′,4,6-tetrahydroxybenzophenone synthase EC 2.3.1.152: alcohol O-cinnamoyltransferase EC 2.3.1.153: anthocyanin 5-(6′′′-hydroxycinnamoyltransferase) EC 2.3.1.154: Now EC 2.3.1.176 EC 2.3.1.155: acetyl-CoA C-myristoyltransferase EC 2.3.1.156: phloroisovalerophenone synthase EC 2.3.1.157: glucosamine-1-phosphate N-acetyltransferase EC 2.3.1.158: phospholipid:diacylglycerol acyltransferase EC 2.3.1.159: acridone synthase EC 2.3.1.160: vinorine synthase EC 2.3.1.161: lovastatin nonaketide synthase EC 2.3.1.162: taxadien-5α-ol O-acetyltransferase EC 2.3.1.163: 10-hydroxytaxane O-acetyltransferase EC 2.3.1.164: isopenicillin-N N-acyltransferase EC 2.3.1.165: 6-methylsalicylic acid synthase EC 2.3.1.166: 2α-hydroxytaxane 2-O-benzoyltransferase EC 2.3.1.167: 10-deacetylbaccatin III 10-O-acetyltransferase EC 2.3.1.168: dihydrolipoyllysine-residue (2-methylpropanoyl)transferase EC 2.3.1.169: CO-methylating acetyl-CoA synthase EC 2.3.1.170: 6′-deoxychalcone synthase EC 2.3.1.171: anthocyanin 6′′-O-malonyltransferase EC 2.3.1.172: anthocyanin 5-O-glucoside 6′′′-O-malonyltransferase EC 2.3.1.173: flavonol-3-O-triglucoside O-coumaroyltransferase EC 2.3.1.174: 3-oxoadipyl-CoA thiolase EC 2.3.1.175: deacetylcephalosporin-C acetyltransferase EC 2.3.1.176: propanoyl-CoA C-acyltransferase EC 2.3.1.177: 3,5-dihydroxybiphenyl synthase EC 2.3.1.178: diaminobutyrate acetyltransferase EC 2.3.1.179: β-ketoacyl-[acyl-carrier-protein] synthase II EC 2.3.1.180: β-ketoacyl-[acyl-carrier-protein] synthase III EC 2.3.1.181: lipoyl(octanoyl) transferase EC 2.3.1.182: Now covered by EC 2.3.3.21 EC 2.3.1.183: phosphinothricin acetyltransferase EC 2.3.1.184: acyl-homoserine-lactone synthase EC 2.3.1.185: tropine acyltransferase EC 2.3.1.186: pseudotropine acyltransferase EC 2.3.1.187: acetyl-S-ACP:malonate ACP transferase EC 2.3.1.188: ω-hydroxypalmitate O-feruloyl transferase EC 2.3.1.189: mycothiol synthase EC 2.3.1.190: acetoin dehydrogenase EC 2.3.1.191: UDP-3-O-(3-hydroxyacyl)glucosamine N-acyltransferase EC 2.3.1.192: glycine N-phenylacetyltransferase EC 2.3.1.193: tRNAMetcytidine acetyltransferase EC 2.3.1.194: acetoacetyl-CoA synthase EC 2.3.1.195: (Z)-3-hexen-1-ol acetyltransferase EC 2.3.1.196: benzyl alcohol O-benzoyltransferase EC 2.3.1.197: dTDP-3-amino-3,6-dideoxy-α-D-galactopyranose 3-N-acetyltransferase EC 2.3.1.198: glycerol-3-phosphate 2-O-acyltransferase EC 2.3.1.199: very-long-chain 3-oxoacyl-CoA synthase EC 2.3.1.200: lipoyl amidotransferase EC 2.3.1.201: UDP-2-acetamido-3-amino-2,3-dideoxy-glucuronate N-acetyltransferase EC 2.3.1.202: UDP-4-amino-4,6-dideoxy-N-acetyl-β-L-altrosamine N-acetyltransferase EC 2.3.1.203: UDP-N-acetylbacillosamine N-acetyltransferase EC 2.3.1.204: octanoyl-[GcvH]:protein N-octanoyltransferase EC 2.3.1.205: fumigaclavine B O-acetyltransferase EC 2.3.1.206: 3,5,7-trioxododecanoyl-CoA synthase EC 2.3.1.207: β-ketodecanoyl-[acyl-carrier-protein] synthase EC 2.3.1.208: 4-hydroxycoumarin synthase EC 2.3.1.209: dTDP-4-amino-4,6-dideoxy-D-glucose acyltransferase EC 2.3.1.210: dTDP-4-amino-4,6-dideoxy-D-galactose acyltransferase EC 2.3.1.211: bisdemethoxycurcumin synthase EC 2.3.1.212: benzalacetone synthase EC 2.3.1.213: cyanidin 3-O-(6-O-glucosyl-2-O-xylosylgalactoside) 6′′′-O-hydroxycinnamoyltransferase EC 2.3.1.214: pelargonidin 3-O-(6-caffeoylglucoside) 5-O-(6-O-malonylglucoside) 4′′′-malonyltransferase EC 2.3.1.215: anthocyanin 3-O-glucoside 6-O-hydroxycinnamoyltransferase EC 2.3.1.216: 5,7-dihydroxy-2-methylchromone synthase EC 2.3.1.217: curcumin synthase EC 2.3.1.218: phenylpropanoylacetyl-CoA synthase EC 2.3.1.219: demethoxycurcumin synthase EC 2.3.1.220: 2,4,6-trihydroxybenzophenone synthase EC 2.3.1.221: noranthrone synthase EC 2.3.1.222: phosphate propanoyltransferase EC 2.3.1.223: 3-oxo-5,6-didehydrosuberyl-CoA thiolase EC 2.3.1.224: acetyl-CoA-benzylalcohol acetyltransferase EC 2.3.1.225: protein S-acyltransferase EC 2.3.1.226: carboxymethylproline synthase EC 2.3.1.227: GDP-perosamine N-acetyltransferase EC 2.3.1.228: isovaleryl-homoserine lactone synthase EC 2.3.1.229: 4-coumaroyl-homoserine lactone synthase EC 2.3.1.230: 2-heptyl-4(1H)-quinolone synthase EC 2.3.1.231: tRNAPhe {7-[3-amino-3-(methoxycarbonyl)propyl]wyosine37 -N}-methoxycarbonyltransferase EC 2.3.1.232: methanol O-anthraniloyltransferase EC 2.3.1.233: 1,3,6,8-tetrahydroxynaphthalene synthase EC 2.3.1.234: N6-L-threonylcarbamoyladenine synthase EC 2.3.1.235: tetracenomycin F2 synthase EC 2.3.1.236: 5-methylnaphthoic acid synthase EC 2.3.1.237: neocarzinostatin naphthoate synthase EC 2.3.1.238: monacolin J acid methylbutanoate transferase EC 2.3.1.239: 10-deoxymethynolide synthase EC 2.3.1.240: narbonolide synthase EC 2.3.1.241: Kdo2-lipid IVA lauroyltransferase EC 2.3.1.242: Kdo2-lipid IVA palmitoleoyltransferase EC 2.3.1.243: lauroyl-Kdo2-lipid IVA myristoyltransferase EC 2.3.1.244: 2-methylbutanoate polyketide synthase EC 2.3.1.245: 3-hydroxy-5-phosphooxypentane-2,4-dione thiolase EC 2.3.1.246: 3,5-dihydroxyphenylacetyl-CoA synthase EC 2.3.1.247: 3-keto-5-aminohexanoate cleavage enzyme EC 2.3.1.248: spermidine disinapoyl transferase EC 2.3.1.249: spermidine dicoumaroyl transferase EC 2.3.1.250: [Wnt protein] O-palmitoleoyl transferase EC 2.3.1.251: lipid IVA palmitoyltransferase EC 2.3.1.252: mycolipanoate synthase EC 2.3.1.253: phloroglucinol synthase EC 2.3.1.254: N-terminal methionine Nα-acetyltransferase NatB EC 2.3.1.255: N-terminal amino-acid Nα-acetyltransferase NatA EC 2.3.1.256: N-terminal methionine Nα-acetyltransferase NatC EC 2.3.1.257: N-terminal L-serine Nα-acetyltransferase NatD EC 2.3.1.258: N-terminal methionine Nα-acetyltransferase NatE EC 2.3.1.259: N-terminal methionine Nα-acetyltransferase NatF EC 2.3.1.260: tetracycline polyketide synthase EC 2.3.1.261: (4-hydroxyphenyl)alkanoate synthase EC 2.3.1.262: anthraniloyl-CoA anthraniloyltransferase EC 2.3.1.263: 2-amino-4-oxopentanoate thiolase EC 2.3.1.264: β-lysine N6-acetyltransferase EC 2.3.1.265: phosphatidylinositol dimannoside acyltransferase EC 2.3.1.266: [ribosomal protein S18]-alanine N-acetyltransferase EC 2.3.1.267: [ribosomal protein S5]-alanine N-acetyltransferase EC 2.3.1.268: ethanol O-acetyltransferase EC 2.3.1.269: apolipoprotein N-acyltransferase EC 2.3.1.270: lyso-ornithine lipid O-acyltransferase EC 2.3.1.271: L-glutamate-5-semialdehyde N-acetyltransferase EC 2.3.1.272: 2-acetylphloroglucinol acetyltransferase EC 2.3.1.273: diglucosylglycerate octanoyltransferase EC 2.3.1.274: phosphate acyltransferase EC 2.3.1.275: acyl phosphate:glycerol-3-phosphate acyltransferase EC 2.3.1.276: galactosamine-1-phosphate N-acetyltransferase EC 2.3.1.277: 2-oxo-3-(phosphooxy)propyl 3-oxoalkanoate synthase EC 2.3.1.278: mycolipenoyl-CoA—2-(long-chain-fatty acyl)-trehalose mycolipenoyltransferase EC 2.3.1.279: long-chain-acyl-CoA—trehalose acyltransferase EC 2.3.1.280: (aminoalkyl)phosphonate N-acetyltransferase EC 2.3.1.281: 5-hydroxydodecatetraenal polyketide synthase EC 2.3.1.282: phenolphthiocerol/phthiocerol/phthiodiolone dimycocerosyl transferase EC 2.3.1.283: 2′-acyl-2-O-sulfo-trehalose (hydroxy)phthioceranyltransferase EC 2.3.1.284: 3′-(hydroxy)phthioceranyl-2′-palmitoyl(stearoyl)-2-O-sulfo-trehalose (hydroxy)phthioceranyltransferase EC 2.3.1.285: (13S,14R)-1,13-dihydroxy-N-methylcanadine 13-O-acetyltransferase EC 2.3.1.286: protein acetyllysine N-acetyltransferase EC 2.3.1.287: phthioceranic/hydroxyphthioceranic acid synthase EC 2.3.1.288: 2-O-sulfo trehalose long-chain-acyltransferase EC 2.3.1.289: aureothin polyketide synthase system EC 2.3.1.290: spectinabilin polyketide synthase system EC 2.3.1.291: sphingoid base N-palmitoyltransferase EC 2.3.1.292: (phenol)carboxyphthiodiolenone synthase EC 2.3.1.293: meromycolic acid 3-oxoacyl-(acyl carrier protein) synthase I EC 2.3.1.294: meromycolic acid 3-oxoacyl-(acyl carrier protein) synthase II EC 2.3.1.295: mycoketide-CoA synthase EC 2.3.1.296: ω-hydroxyceramide transacylase EC 2.3.1.297: very-long-chain ceramide synthase EC 2.3.1.298: ultra-long-chain ceramide synthase EC 2.3.1.299: sphingoid base N-stearoyltransferase EC 2.3.1.300: branched-chain β-ketoacyl-[acyl-carrier-protein] synthase EC 2.3.1.301: mycobacterial β-ketoacyl-[acyl carrier protein] synthase III EC 2.3.1.302: hydroxycinnamoyl-CoA:5-hydroxyanthranilate N-hydroxycinnamoyltransferase EC 2.3.1.303: α-L-Rha-(1→2)-α-D-Man-(1→2)-α-D-Man-(1→3)-α-D-Gal-PP-Und 2IV-O-acetyltransferase EC 2.3.1.304: poly[(S)-3-hydroxyalkanoate] polymerase
Protein nuclear magnetic resonance is performed on aqueous samples of highly purified protein. Usually, the sample consists of between 300 and 600 microlitres with a protein concentration in the range 0.1 – 3 millimolar. The source of the protein can be either natural or produced in a production system using recombinant DNA techniques through genetic engineering. Recombinantly expressed proteins are usually easier to produce in sufficient quantity, and this method makes isotopic labeling possible. The purified protein is usually dissolved in a buffer solution and adjusted to the desired solvent conditions. The NMR sample is prepared in a thin-walled glass tube.
=== Government Day === Breakthrough T1D’s Government Day is an annual event where volunteer advocates tell their stories to illustrate the financial, medical, and emotional costs of type 1 diabetes to national leaders in the U.S. and help develop policy responses.
In November 1965 the government of the British colony of Southern Rhodesia issued an illegal Unilateral Declaration of Independence. This government represented the country's small white minority and was led by Prime Minister Ian Smith. The black majority of the population had little influence on the government, which sought to continue white racial privileges. At the time of independence the Rhodesian Security Forces were relatively large and well trained and equipped. Two groups with armed elements emerged as the opposition to the white Rhodesian regime. These were the Zimbabwe African National Union (ZANU), whose military wing was the Zimbabwe African National Liberation Army (ZANLA), and the Zimbabwe African People's Union (ZAPU) and its armed wing the Zimbabwe People's Revolutionary Army (ZIPRA). Both groups were initially based in Zambia, and from the late 1960s began dispatching insurgents into Rhodesia who used guerrilla tactics. These attacks initially proved ineffective and the Rhodesian military, which had been bolstered by forces from South Africa, was able to effectively counter them. Rhodesia's security situation began to deteriorate from late 1972, when the guerrilla armies began making more effective attacks in the north-east of the country. The collapse of the Portuguese Empire in 1975 that led to the independence of Mozambique led to a further increase to the challenges facing the Rhodesian regime, with the guerrillas using that country as well as Botswana as bases.
Sources: en.wikipedia.org
While most cephalopods can move by jet propulsion, this is a very energy-consuming way to travel compared to the tail propulsion used by fish. The efficiency of a propeller-driven waterjet (i.e. Froude efficiency) is greater than a rocket. The relative efficiency of jet propulsion decreases further as animal size increases; paralarvae are far more efficient than juvenile and adult individuals. Since the Paleozoic era, as competition with fish produced an environment where efficient motion was crucial to survival, jet propulsion has taken a back role, with fins and tentacles used to maintain a steady velocity. Whilst jet propulsion is never the sole mode of locomotion, the stop-start motion provided by the jets continues to be useful for providing bursts of high speed – not least when capturing prey or avoiding predators. Indeed, it makes cephalopods the fastest marine invertebrates, and they can out-accelerate most fish. The jet is supplemented with fin motion; in the squid, the fins flap each time that a jet is released, amplifying the thrust; they are then extended between jets (presumably to avoid sinking). Oxygenated water is taken into the mantle cavity to the gills and through muscular contraction of this cavity, the spent water is expelled through the hyponome, created by a fold in the mantle. The size difference between the posterior and anterior ends of this organ control the speed of the jet the organism can produce. The velocity of the organism can be accurately predicted for a given mass and morphology of animal.
Vanguard S&P Small-Cap 600 ETF (NYSE Arca: VIOO) SPDR Portfolio S&P 600 Small Cap ETF (NYSE Arca: SPSM) iShares Core S&P Small-Cap ETF (NYSE Arca: IJR) These index funds may be reconstituted at different intervals resulting in a small difference in holdings.
=== Total triiodothyronine === Total triiodothyronine (Total T3) is rarely measured, having been largely superseded by free T3 tests. Total T3 is generally elevated in hyperthyroidism and decreased in hypothyroidism. Reference ranges depend on the method of analysis. Results should always be interpreted using the range from the laboratory that performed the test. Example values are:
Some increases in fentanyl deaths do not involve prescription fentanyl but are related to illicitly made fentanyl that is being mixed with or sold as heroin. In 2017 the death rate increased by more than 100% with 368 overdose-related deaths in British Columbia between January and April 2017.
The Special Collections hold rare and archival materials mainly in the areas of literature, Arizona and Southwestern history, and the sciences. The Special Collections also have important and substantial collections relating to the lands and peoples of Arizona and the US-Mexican borderlands region.
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.